SEPN Septerna, Inc.

$44.50

Septerna, Inc. (SEPN) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.52 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.5% since its last earnings release on August 10, 2026.

Septerna Beat Consensus Estimates
Monday, August 10, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs ($0.52)
Rev est $25.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $46.79

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Septerna, Inc.

Septerna Inc. is a clinical-stage biotechnology company pioneering a new era of GPCR oral small molecule drug discovery powered by its proprietary Native Complex Platform(TM). Septerna Inc. is based in SOUTH SAN FRANCISCO, Calif.

Sector

Healthcare

Industry

Biotechnology